Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence
Conditions
- Opioid-Related Disorders
- Opiate Dependence
Interventions
- DRUG: Buprenorphine/naloxone sublingual tablets
- DRUG: Buprenorphine
Sponsor
Orexo AB
Collaborators